Boundless Bio’s announcement earlier this month of plans to go public was a sign that the biotech IPO window hadn’t slammed shut after a flurry of offerings at the start of the year. Now, the company ...
SEATTLE, October 01, 2025--(BUSINESS WIRE)--Boundless Immigration, the leading force for change in global immigration and workforce mobility, today announced its acquisition of Localyze, a premier ...
The Boundless team has grown to 28 employees in the company’s first two years. (Boundless Photo) In the two years since it launched, Boundless has become the top destination for immigrants applying ...
Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...
NEW YORK, NY / ACCESSWIRE / March 9, 2022 / Fitness is an essential part of life. Whether you work out to help improve your mood, your health, or you are just doing it for fun, it is crucial to many ...
Boundless Bio, the precision oncology company working on treatments for oncogene-amplified cancers, is amping up its fundraising with a new $100 million series C round backed by Leaps by Bayer and RA ...
A Quick Take On Boundless Bio, Inc. Boundless Bio, Inc. (BOLD) has filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement, although the final figure ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Apr 22, 2021 at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results